Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Mounjaro is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes and weight management in the UK
Ongoing Care Your physician monitors your progress month to month and adjusts your dose as your body adapts no office visits, just message your care team
Initially, semaglutide treatment begins at the lowest effective dose and is progressively increased as your body adjusts, ensuring effective and sustainable weight loss
HSA and FSA bridging: Patients with remaining HSA or FSA balances can apply pre-tax funds to Direct Meds costs immediately using existing pre-tax health account assets during the coverage gap period
Movement and exercise protocols that restore gut motility Your colon responds to movement
